METASTATIC NSCLC - NON-SMALL CELL LUNG CANCER
Clinical trials for METASTATIC NSCLC - NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC NSCLC - NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for METASTATIC NSCLC - NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gentler chemo combo aims to help older lung cancer patients live longer with fewer side effects
Disease control Recruiting nowThis study tests whether a reduced dose of chemotherapy combined with the immunotherapy drug cemiplimab works better than cemiplimab alone for people aged 70 and older with advanced non-small cell lung cancer. Participants must be in relatively poor health or frail, and their tum…
Matched conditions: METASTATIC NSCLC - NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Swiss Cancer Institute • Aim: Disease control
Last updated May 17, 2026 03:24 UTC
-
New hope for lung cancer patients too frail for standard chemo
Disease control Recruiting nowThis study tests a combination of the targeted drug amivantamab plus a single chemotherapy drug in people with advanced non-small cell lung cancer that has a specific EGFR mutation (exon20 insertion). Participants must not have had prior treatment and must be unable to receive st…
Matched conditions: METASTATIC NSCLC - NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Fondazione Ricerca Traslazionale • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Blood cells may hold key to lung cancer treatment success
Knowledge-focused Recruiting nowThis study is for people with advanced non-small cell lung cancer who are starting the immunotherapy drug nivolumab. Researchers want to see if the level of certain immune cells, called large granular lymphocytes, in the blood can help predict how well the treatment works. About …
Matched conditions: METASTATIC NSCLC - NON-SMALL CELL LUNG CANCER
Sponsor: Necmettin Erbakan University • Aim: Knowledge-focused
Last updated May 13, 2026 15:58 UTC